Skip to main content

Cell Therapeutics, Inc. (NASDAQ:CTIC) Faces Yet Another Investor Investigation Over Possible New Securities Laws Violations

  • If you purchased shares of Cell Therapeutics, Inc. (NASDAQ:CTIC) in 2011 or 2012, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

San Diego, Feb. 14, 2012 (Shareholders Foundation) -- An new investigation on behalf of investors in shares of Cell Therapeutics, Inc. (NASDAQ:CTIC) was announced over new potential securities laws violations by certain officers and directors at Cell Therapeutics in connection with its statements in regards to its New Drug Application for Pixuvri(TM). The new investigation by a law fi...



You must register (for free) or login to view the entire investigation.